Based on SEC filing data. A biotech corporation in South San Francisco has raised $106.0 million in equity funding and is in the growth stage. The company operates in the biotechnology sector.
Get notified the moment NGM BIOPHARMACEUTICALS INC files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.